title: Molecular determinants of chemotherapy resistance in ovarian cancer.
authors.affiliation: Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
authors.forename: Megan
authors.initials: M
authors.lastname: Cooley
authors.affiliation: Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
authors.forename: Pingping
authors.initials: P
authors.lastname: Fang
authors.affiliation: Department of Cellular & Integrative Physiology, Medical Sciences Program, Indiana University, Bloomington, IN 47405, USA.
authors.forename: Fang
authors.initials: F
authors.lastname: Fang
authors.forename: Kenneth P
authors.initials: KP
authors.lastname: Nephew
authors.affiliation: Department of Cellular & Integrative Physiology, Medical Sciences Program, Indiana University, Bloomington, IN 47405, USA.
authors.forename: Kenneth
authors.initials: K
authors.lastname: P Nephew
authors.affiliation: Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Chien
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002945:Cisplatin / Q000494:pharmacology / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000187:drug effects / Q000235:genetics*; D005260:Female; D023281:Genomics / Q000639:trends; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin
keywords: cancer genomics; chemotherapy; functional genomics; heterogeneity; intra-tumor; ovarian cancer; resistance